The predictive value of NLR, MLR, and PLR in the outcome of end-stage kidney disease patients
AV Mureșan, E Russu, EM Arbănași, R Kaller, I Hosu… - Biomedicines, 2022 - mdpi.com
Background: Chronic kidney disease (CKD) is a global public health problem with a high
mortality rate and a rapid progression to end-stage kidney disease (ESKD). Recently, the …
mortality rate and a rapid progression to end-stage kidney disease (ESKD). Recently, the …
Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and …
WM Zhao, SM Tao, GL Liu - Renal failure, 2020 - Taylor & Francis
Aim To systematically evaluate the relationship between the neutrophil-to-lymphocyte ratio
(NLR) and the risk of all-cause mortality or cardiovascular events in patients with chronic …
(NLR) and the risk of all-cause mortality or cardiovascular events in patients with chronic …
[HTML][HTML] Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as biological markers of interest in kidney disease
Inflammation is one of the central pathophysiological factors in kidney disease. Nowadays,
we have widely recognised diagnostic and monitoring markers, such as C-reactive protein …
we have widely recognised diagnostic and monitoring markers, such as C-reactive protein …
The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels' Diameters in Arteriovenous Fistula Maturation Failure
Background: An arteriovenous fistula (AVF) is the first-line vascular access pathway for
patients diagnosed with end-stage renal disease (ESRD). In planning vascular access, it is …
patients diagnosed with end-stage renal disease (ESRD). In planning vascular access, it is …
High neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio are associated with poor survival in patients with hemodialysis
J Zhang, X Lu, S Wang, H Li - BioMed Research International, 2021 - Wiley Online Library
Background. The neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio
(PLR) are markers for systemic inflammation condition. Although NLR has emerged as a risk …
(PLR) are markers for systemic inflammation condition. Although NLR has emerged as a risk …
Lymphocyte cell ratios and mortality among incident hemodialysis patients
Background: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR)
have been previously suggested as oncologic prognostication markers. These are …
have been previously suggested as oncologic prognostication markers. These are …
Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all‐cause mortality in hemodialysis patients: a prospective cohort study
F Xiang, R Chen, X Cao, B Shen, Z Liu… - Hemodialysis …, 2018 - Wiley Online Library
Introduction: Patients with chronic kidney disease, especially those with end‐stage renal
disease, have an increased risk of death. Previous studies have suggested …
disease, have an increased risk of death. Previous studies have suggested …
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort
KJ Mayne, JS Lees, E Rutherford… - Clinical kidney …, 2023 - academic.oup.com
Background Lymphocyte ratios reflect inflammation and have been associated with adverse
outcomes in a range of diseases. We sought to determine any association between …
outcomes in a range of diseases. We sought to determine any association between …
Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on …
J Liao, D Wei, C Sun, Y Yang, Y Wei, X Liu - BMC nephrology, 2022 - Springer
Background Hemodialysis (HD) is the most important renal replacement therapy for patients
with end-stage kidney disease (ESKD). Systemic inflammation is a risk factor of mortality in …
with end-stage kidney disease (ESKD). Systemic inflammation is a risk factor of mortality in …
Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing …
E Bressi, F Mangiacapra, E Ricottini, I Cavallari… - Journal of …, 2018 - Springer
The prognostic role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio
(PLR) in patients with stable coronary artery disease (CAD) is still unclear. We enrolled 500 …
(PLR) in patients with stable coronary artery disease (CAD) is still unclear. We enrolled 500 …